Vol 1, No 1 (June 01, 2012): Translational Cancer Research

Editorials

Translational Cancer Research - Message from the Editor-in-Chief
Eric Y Chuang, Sc.D.
Translational Cancer Research  
2012;
1
(1)
:1
.
 (01 June 2012) 
PDF Full Text (5982) COI Form Open Access Get Permission
DNA-PK targeting virotherapy, a promising approach
Koji Tsuboi
Translational Cancer Research  
2012;
1
(1)
:2-3
.
 (01 June 2012) 
PDF Full Text (5779) COI Form Open Access Get Permission
Inhibitors of DNA repair for cancer therapy, ready for prime time?
Chuan-Yuan Li
Translational Cancer Research  
2012;
1
(1)
:4-5
.
 (01 June 2012) 
PDF Full Text (3311) COI Form Open Access Get Permission

Original Article

Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA
Takashi Kon, Xiuwu Zhang, Qian Huang, Zhonghui Yang, Shanling Liu, Bin Yan, Fang Li, He Wang, Chuan-Yuan Li
Translational Cancer Research  
2012;
1
(1)
:6-14
.
 (01 June 2012) 
PDF Full Text (7887) COI Form Open Access Get Permission

Review Articles

SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis
Seong-Hoon Park, Yuming Zhu, Ozkan Ozden, Hyun-Seok Kim, Haiyan Jiang, Chu-Xia Deng, David Gius, Athanassios Vassilopoulos
Translational Cancer Research  
2012;
1
(1)
:15-21
.
 (01 June 2012) 
PDF Full Text (16262) COI Form Open Access Get Permission
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment
Feng-Ming Hsu, Shichuan Zhang, Benjamin P.C. Chen
Translational Cancer Research  
2012;
1
(1)
:22-34
.
 (01 June 2012) 
PDF Full Text (17398) COI Form Open Access Get Permission
Normal tissue protection for improving radiotherapy: where are the Gaps?
Pataje G.S. Prasanna, Helen B. Stone, Rosemary S. Wong, Jacek Capala, Eric J. Bernhard, Bhadrasain Vikram, C. N. Coleman
Translational Cancer Research  
2012;
1
(1)
:35-48
.
 (01 June 2012) 
PDF Full Text (19512) COI Form Open Access Get Permission

Perspective

Anti-HER2 therapies: when more is more
Monica Arnedos, Britta Weigelt, Jorge S. Reis-Filho
Translational Cancer Research  
2012;
1
(1)
:49-54
.
 (01 June 2012) 
PDF Full Text (7406) COI Form Open Access Get Permission

Research Highlights

Bevacizumab: where do we go from here in breast cancer?
Faina Nakhlis, Mehra Golshan
Translational Cancer Research  
2012;
1
(1)
:55-56
.
 (01 June 2012) 
PDF Full Text (2923) COI Form Open Access Get Permission
Neoadjuvant bevacizumab and chemotherapy in breast cancer
Suparna B. Wedam, Sherry X. Yang
Translational Cancer Research  
2012;
1
(1)
:57-58
.
 (01 June 2012) 
PDF Full Text (3914) COI Form Open Access Get Permission